The effect of natalizumab therapy on executive function, fatigue and depression in patients with multiple sclerosis

被引:0
|
作者
Jonsdottir, S. [1 ,2 ]
Hjaltason, H. [1 ,2 ]
Prainsdottir, S. [1 ,2 ]
机构
[1] Univ Iceland, Natl Univ Hosp Iceland, Landspitali, Reykjavik, Iceland
[2] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:724 / 724
页数:1
相关论文
共 50 条
  • [31] Fatigue and depression in multiple sclerosis
    Patten, SB
    Metz, LM
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2000, 45 (01): : 84 - 85
  • [32] Fatigue and depression in multiple sclerosis
    Alper, Y
    Yüceyar, N
    Kocaman, A
    MULTIPLE SCLEROSIS JOURNAL, 2004, 10 : S127 - S127
  • [33] The effect of exercise therapy on fatigue in multiple sclerosis
    Andreasen, A. K.
    Stenager, E.
    Dalgas, U.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (09) : 1041 - 1054
  • [34] Effect of natalizumab on counts and function on natural regulatory T-cells in patients with multiple sclerosis
    Kumar, Manoj
    Hellwig, Kerstin
    Kreutzfelder, Erich
    Rutzki, Norman
    NEUROLOGY, 2008, 70 (11) : A383 - A383
  • [35] Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients
    Sainz-Amo, Raquel
    Rodero-Romero, Alexander
    Monreal, Enric
    Chico-Garcia, Juan Luis
    Rodriguez-Jorge, Fernando
    Fernandez-Velasco, Jose Ignacio
    Villarrubia, Noelia
    Veiga-Gonzalez, Jose Luis
    de la Maza, Susana Sainz
    Masjuan, Jaime
    Costa-Frossard, Lucienne
    Villar, Luisa Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [36] Natalizumab reduces loss of visual function in patients with relapsing multiple sclerosis
    Balcer, L
    Galetta, SL
    O'Connor, PW
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, DH
    Phillips, JT
    Polman, CH
    Stuart, WH
    Calabresi, PA
    Confavreux, C
    Radue, EW
    Rudick, RA
    Lublin, FD
    Giovannoni, G
    Wajgt, A
    Weinstock-Guttman, B
    Wynn, DR
    Lynn, FA
    Panzara, MA
    Sandrock, AW
    NEUROLOGY, 2006, 66 (05) : A251 - A251
  • [37] Effect of natalizumab on counts and function on natural regulatory T-cells in patients with multiple sclerosis
    Kumar, M.
    Putzki, N.
    Grosse-Wilde, H.
    Kreuzfelder, E.
    MULTIPLE SCLEROSIS, 2007, 13 : S33 - S34
  • [38] The effect of natalizumab therapy on immune surveillance of the central nervous system in multiple sclerosis patients.
    Stuve, Olaf
    Marra, Christina
    Jerome, Keith
    Cook, Linda
    Cravens, Petra
    Cepok, Sabine
    Frohman, Elliot
    Phillips, Theodore
    Arendt, Gabriele
    Hemmer, Bernhard
    Monson, Nancy
    Racke, Michael
    CLINICAL IMMUNOLOGY, 2006, 119 : S47 - S48
  • [39] Use of Natalizumab in Multiple Sclerosis Patients
    O'Connor, Paul W.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2010, 37 (01) : 98 - 104
  • [40] Multiple sclerosis: natalizumab effects on cognitive function
    Gudesblatt, Mark
    Doniger, Glen
    Zarif, Myassar
    Bumstead, Barbara
    Fafard, Lori
    Graffitti, Laura
    Seidel, Carole
    Cruz, Lourdes
    Fahie, Serina
    Bohuslaw, Joan
    Burke, Chris
    Caputo, Jocelyn
    Riley, Susan
    Simon, Ely
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1397 - 1397